I-Neuchatel, Switzerland--(INTAMBO ZEBHIZINISI)-- UMasimo (NASDAQ: MASI) namuhla umemezele imiphumela yocwaningo lokubheka emuva olushicilelwe ku-International Journal of Pediatrics.Kulolu cwaningo, abacwaningi basesibhedlela sase-Osaka Womens and Children's Hospital e-Japan bathole ukuthi I-Masimo EMMA® i-capnometer ephathekayo "ingasetshenziswa ukuhlola isimo sokuphefumula sezingane ezithola i-tracheotomy."1 I-EMMA® itholakala ngendlela ehlangene yeziguli zabo bonke ubudala. akukho ukulinganisa okujwayelekile, kunesikhathi esincane sokufudumala, futhi ibonisa isikhutha esinembile sokuphela kwe-tidal carbon dioxide (EtCO2) nezilinganiso zezinga lokuphefumula kanye ne-EtCO2 waveform eqhubekayo phakathi kwamasekhondi angu-15.
Ephawula inani elingaba khona lendlela ehlangene nephathekayo yokuqapha izinguquko esimweni sokuphefumula kweziguli ezimweni lapho imishini yokuqapha isibhedlela esilalisiwe ingenakwenzeka khona, uDkt. Masashi Hotta nozakwabo bafuna ukuhlola ukusebenza kwe-EMMA capnography ezinganeni ngokuqhathanisa. idatha evela kumanani we-EtCO2 kusuka kudivayisi ye-EMMA (enamathiselwe ekugcineni kwe-tracheostomy tube) kanye nokucindezela okuyingxenye ye-venous ye-carbon dioxide (PvCO2) ye-tracheotomy.Ngenkathi ukucindezela kwengxenye ye-arterial ye-carbon dioxide (PaCO2) kubhekwa njengegolide izinga lokuhlola isimo sokuphefumula, abacwaningi bakhethe i-PvCO2 ngoba "ukuthatha amasampula e-arterial kuhlasela kakhulu kunokuthatha amasampula e-venous," bephawula ukuthi ucwaningo lubonise ukuthi i-PaCO2 ne-PvCO2.2,3 Baqashe izinsana eziyi-9 (iminyaka ephakathi nezinyanga ezingu-8) futhi baqhathanisa isamba esingamapheya angama-43 wokufundwa kwe-EtCO2-PvCO2.
Abacwaningi bathole i-coefficient yokuhlobana phakathi kokufundwa kwe-EtCO2 ne-PvCO2 okungu-0.87 (95% isikhathi sokuzethemba esingu-0.7 – 0.93; p <0.001). Ukuhlaziywa kwedatha kubonise ukuthi ukufundwa kwe-EtCO2 ngokwesilinganiso bekungaphansi kuka-10.0 mmHg kunamanani ahambisanayo e-PvCO2 (95) % umkhawulo wesivumelwano wawungu-1.0 – 19.1 mmHg).Abacwaningi bacabangela ukuthi inkambiso yokuthi i-EtCO2 ibe ngaphansi kune-PvCO2 ingachazwa "ngokuxutshwa kwegesi eduze kweshubhu le-tracheostomy ngenxa yokuba khona kwendawo efile ye-anatomical kanye ne-physiological. Njengoba cishe zonke iziguli zasebenzisa amashubhu angenawo ama-cuffs, kungenzeka lokhu kwenzeke Okunye ukuvuza.Futhi, cishe izingxenye ezimbili kwezintathu zeziguli zine-[isifo samaphaphu esingamahlalakhona noma i-bronchopulmonary dysplasia], eziveze ukuthi zikhonjiswe ukuthi zineqhaza ku-CO2 ngesikhathi sokukhipha umoya uma kuqhathaniswa nokucindezela kwengxenye ye-CO2 egazini Ukugxila kwehle.
Baphinde bathola ukuthi umehluko omaphakathi wokufundwayo okuqoqwe ngenkathi iziguli zithola ukungeniswa komoya ngomshini wawumkhulu kakhulu (amapheya angama-28 kwangu-43) (p = 0.043) .Abacwaningi baphawule ukuthi ukusetshenziswa kwe-ventilator kwakuhlotshaniswa kakhulu nomehluko wokufundwayo okubhanqiwe ngoba iziguli kuma-ventilators zinezimo zokuphefumula noma zokujikeleza kwegazi.
"Sibonisa ubudlelwano obuhle obuqinile phakathi kwe-PvCO2 ne-EtCO2 futhi siveza ukusebenziseka nokusebenziseka kwale capnometer ezinganeni ezithola i-tracheotomy," abacwaningi baphetha ngokuthi, "i-EMMA ingasetshenziselwa Ukuhlola isimo sokuphefumula sezingane ezithola i-tracheotomy. I-EMMA iwusizo ikakhulukazi ku-tracheotomy. izilungiselelo zokunakekelwa kwasekhaya kanye nezilungiselelo zeziguli zangaphandle zezingane ezinjalo."Baphinde baphawula, "Amandla amakhulu alolu cwaningo ukuthi sasebenzisa i-capnometer ephathekayo ukuhlola i-EtCO2."
I-Masimo (NASDAQ: MASI) yinkampani yomhlaba wonke yobuchwepheshe bezokwelapha ethuthukisa futhi ikhiqize ububanzi obubanzi bobuchwepheshe bokuqapha obuhamba phambili embonini, okuhlanganisa izilinganiso ezintsha, izinzwa, iziqapha zesiguli, nezisombululo ezizenzakalelayo nezokuxhuma—Umgomo wethu uwukuthuthukisa isiguli. imiphumela kanye nokunciphisa izindleko zokunakekela.Yethulwa ngo-1995, i-Masimo SET® Measure-through Motion and Low Perfusion™ pulse oximeter ikufakazele ukusebenza kwayo kunobunye ubuchwepheshe be-pulse oximeter ezifundweni ezizimele nezinenjongo ezingaphezu kwe-100.4 I-Masimo SET® nayo iye yahlolwa. kuboniswe ukusiza odokotela behlise i-retinopathy enzima ezinganeni ezisanda kuzalwa,5 ukuthuthukisa ukuhlolwa kwe-CCHD ezinganeni ezisanda kuzalwa,6 futhi kunciphise umzamo weqembu elisabela ngokushesha lapho kusetshenziswa i-Masimo Patient SafetyNet™ ukuze kuqashwe njalo ewodini yangemva kokuhlinzwa.Ukuqalisa, ukudluliselwa kwe-ICU kanye nezindleko. I-7-10 ilinganisela ukuthi i-Masimo SET® izosetshenziswa iziguli ezingaphezu kwezigidi ezingu-200 ezibhedlela ezihamba phambili nezinye izikhungo zezempilo emhlabeni jikelele,11 ngokusho kwe-2020-21 US News & World Report Best Hospitals Honor Roll,11 futhi ingesinye sezibhedlela eziyi-10 eziphezulu ze-9 main pulse oximeters.12 I-Masimo iyaqhubeka nokwenza ngcono i-SET®, futhi ngo-2018 yamemezela ukuthi ukunemba kwe-SpO2 sensor ye-RD SET® ngaphansi kwezimo zokunyakaza kuye kwaba ngcono kakhulu, okuhlinzeka odokotela ngokuqiniseka okukhulu ukuthi amanani e-SpO2 abathembele kuwo abonisa ngokunembile isimo somzimba wesiguli. Ngo-2005, uMasimo wethula ubuchwepheshe be-rainbow® Pulse CO-Oximetry, obuvumela ukuqapha okungahlaseli nokuqhubekayo kwezingxenye zegazi ngaphambilini ezikalwe ngokuhlaselayo kuphela, okuhlanganisa isamba se-hemoglobin (SpHb®). ), okuqukethwe komoyampilo (SpOC™), carboxyhemoglobin (SpCO®), Methemoglobin (SpMet®), Pleth Variability Index (PVi®), RPVi™ (rainbow® PVi) kanye ne-Oxygen Reserve Index (ORi™).Ngo-2013, uMasimo wethula i-Root® Patient Monitoring and Connectivity Platform, eyakhiwe kusukela phansi ukuze ikwazi ukuguquguquka futhi ande ngangokunokwenzeka ukuze kube lula ukwengezwa kobunye ubuchwepheshe beMasimo kanye nokuqapha okuvela eceleni;izengezo ezibalulekile kuMasimo zihlanganisa isizukulwane esilandelayo sokuqapha ukusebenza kwe-SedLine® Brain, O3® region oxygen saturation kanye ne-ISA™ capnography ngeNomoLine® sampling line. sebenzisa ezimeni ezehlukene zemitholampilo nezingezona ezomtholampilo, okuhlanganisa nobuchwepheshe obugqokekayo obungenazintambo njenge-Radius-7® ne-Radius PPG™, amadivayisi aphathekayo afana ne-Rad-67™, i-Fingertip pulse oximeters njenge-MightySat® Rx namadivayisi angakwazi esetshenziswa esibhedlela nasekhaya njenge-Rad-97®.Masimo hospital automation kanye nezixazululo zokuxhuma zigxile epulatifomu yeMasimo Hospital Automation™ futhi zifaka i-Iris® Gateway, iSirona™, Patient SafetyNet, Replica™, Halo ION™, UniView ™, UniView:60™ kanye ne-Masimo SafetyNet™.Ukuze uthole ulwazi olwengeziwe mayelana ne-Masimo nemikhiqizo yayo, vakashela ku-www.masimo.com.Izifundo zomtholampilo ezishicilelwe ngemikhiqizo ye-Masimo zingatholakala kokuthi www.masimo.com/evidence/featured-studies/feature /.
I-ORi ne-RPVi abakayitholi imvume ye-FDA 510(k) futhi ayikwazi ukumakethwa e-United States.Uphawu lwentengiso lwe-Patient SafetyNet lusetshenziswa ngaphansi kwelayisensi ye-University HealthSystem Consortium.
Lokhu kukhululwa kwabezindaba kuhlanganisa izitatimende ezibheke phambili ngaphakathi kwencazelo yeSigaba 27A Somthetho Wezimboni wango-1933 kanye neSigaba 21E se-Securities Exchange Act ka-1934 ngokuphathelene noMthetho Wokuguqula Icala Lokuvikeleka Kwangasese ka-1995.Lezi zitatimende ezibheke phambili zihlanganisa: Ezinye , izitatimende eziphathelene nempumelelo engaba khona ye-EMMA®.Lezi zitatimende ezibheke phambili zisekelwe kulokho okulindelwe manje ngezehlakalo zesikhathi esizayo ezisithintayo futhi zingaphansi kwezingozi nokungaqiniseki, konke okunzima ukukubikezela, okuningi kwakho okungaphezu kwamandla ethu futhi esingase sikwazi. kubangela ukuthi imiphumela yethu yangempela yehluke kuleyo ebangelwa ubungozi obuhlukahlukene Izinto ezinomthelela ezingozini esiziveza ezitatimendeni zethu ezibheke phambili zihlanganisa, kodwa azikhawulelwe kulokhu: izingozi ezihlobene nokucabangela kwethu mayelana nokuphindaphindeka kwemiphumela yomtholampilo;okuhlobene nenkolelo yethu yokuthi ubuchwepheshe be-Masimo obuyingqayizivele bokulinganisa okungahlanyisi, okuhlanganisa i-EMMA, buneqhaza ezingozini ezinhle zomtholampilo ezihlobene nemiphumela nokuphepha kwesiguli;izingozi ezihlobene nenkolelo yethu yokuthi ukuphumelela kwezokwelapha okungahlaseli kukaMasimo kunikeza izixazululo ezingabizi kanye nezinzuzo eziyingqayizivele;izingozi ezihlobene ne-COVID-19;kanye nezicelo zethu ku-Securities and Exchange Commission ("SEC") Izici ezengeziwe okuxoxwe ngazo esigabeni "Izici Zobungozi" sombiko wakamuva zitholakala mahhala kuwebhusayithi ye-SEC kokuthi www.sec.gov.Nakuba sikholelwa ukuthi okulindelekile okuvezwe ezitatimendeni zethu zokubhekela phambili kunengqondo, asazi noma esikulindele kuzobonakala kuyiqiniso.Zonke izitatimende ezibheke phambili eziqukethwe kulolu shicilelo lwabezindaba zifaneleka ngokuphelele ngokuphelele yilezi zitatimende eziyisixwayiso ezingenhla.Sicela uqaphele sithembela ngokungafanele kulezi zitatimende ezibheke phambili, ezikhuluma namuhla kuphela.Asenzi sibophezelo sokubuyekeza, ukubuyekeza noma ukucacisa lezi zitatimende noma "Izici Zobungozi" eziqukethwe embikweni wethu wakamuva we-SEC, noma ngabe kungenxa yolwazi olusha. , imicimbi yesikhathi esizayo noma okunye, ngaphandle kwalokho okungadingeka ngaphansi kwemithetho yezibambiso esebenzayo.
Ucwaningo olusha luthola ukuthi iMasimo EMMA® Capnograph ingasetshenziswa ukuhlola ukuphefumula kwezingane ezine-tracheostomy.
Isikhathi sokuthumela: Jun-20-2022